生存期-话题@MedSci

#生存期#

350篇内容 | 3611人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1378209, encodeId=0e4713e8209c4, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Radiology：直肠癌晚期壁外静脉受侵MRI征象与肿瘤复发和整体生存期的关系, objectType=article, longId=162959, objectId=fbd6162959ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fbd6162959ca, replyNumber=0, likeNumber=63, createdTime=2019-03-27, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fbd6162959ca, moduleTitle=Radiology：直肠癌晚期壁外静脉受侵MRI征象与肿瘤复发和整体生存期的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fbd6162959ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378208, encodeId=c9f013e820884, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Radiology：容积多参数MRI在预测型经导管动脉化学栓塞术后不可切除性肝内胆管细胞癌的生存期, objectType=article, longId=162550, objectId=4de416255001, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4de416255001, replyNumber=0, likeNumber=58, createdTime=2019-03-20, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4de416255001, moduleTitle=Radiology：容积多参数MRI在预测型经导管动脉化学栓塞术后不可切除性肝内胆管细胞癌的生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4de416255001)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378207, encodeId=e9f613e8207d0, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=BMJ：英国心衰患者生存期变化趋势研究——2000-2017, objectType=article, longId=160637, objectId=153b16063ec4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=153b16063ec4, replyNumber=0, likeNumber=92, createdTime=2019-02-22, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=153b16063ec4, moduleTitle=BMJ：英国心衰患者生存期变化趋势研究——2000-2017, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=153b16063ec4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378206, encodeId=d56313e82063e, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=人工智能可以预测卵巢癌患者的生存期吗？, objectType=article, longId=160401, objectId=d60d16040105, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d60d16040105, replyNumber=0, likeNumber=79, createdTime=2019-02-20, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d60d16040105, moduleTitle=人工智能可以预测卵巢癌患者的生存期吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d60d16040105)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378205, encodeId=b6f913e820568, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Radiology：胶质母细胞瘤MRI放射组学亚型对预测生存期的价值, objectType=article, longId=159881, objectId=3dc315988189, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dc315988189, replyNumber=0, likeNumber=76, createdTime=2019-02-15, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dc315988189, moduleTitle=Radiology：胶质母细胞瘤MRI放射组学亚型对预测生存期的价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3dc315988189)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378204, encodeId=940213e8204e5, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Lancet Oncol：雷莫芦单抗Ⅲ期REACH-2研究获成功，AFP升高的晚期肝细胞癌患者生存期显著改善, objectType=article, longId=159866, objectId=1aab15986606, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1aab15986606, replyNumber=0, likeNumber=78, createdTime=2019-02-14, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1aab15986606, moduleTitle=Lancet Oncol：雷莫芦单抗Ⅲ期REACH-2研究获成功，AFP升高的晚期肝细胞癌患者生存期显著改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1aab15986606)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378203, encodeId=a20213e820363, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=BLOOD：阿扎胞苷治疗可改善老年AML患者的无病生存期, objectType=article, longId=157956, objectId=c45215e95657, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c45215e95657, replyNumber=0, likeNumber=117, createdTime=2019-01-15, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c45215e95657, moduleTitle=BLOOD：阿扎胞苷治疗可改善老年AML患者的无病生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c45215e95657)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378202, encodeId=201d13e82028c, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=CA-Cancer J Clin：**医学期刊CA发文-生存期可超过10年！手术为转移性软组织肉瘤患者带来生存获益, objectType=article, longId=157729, objectId=3f5515e72907, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f5515e72907, replyNumber=0, likeNumber=81, createdTime=2019-01-11, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f5515e72907, moduleTitle=CA-Cancer J Clin：**医学期刊CA发文-生存期可超过10年！手术为转移性软组织肉瘤患者带来生存获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f5515e72907)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378201, encodeId=5d7f13e820140, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=JAMA Intern Med：癌症临床试验：无进展生存期更长表明患者生活质量更佳？, objectType=article, longId=157462, objectId=fd3615e46273, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd3615e46273, replyNumber=0, likeNumber=66, createdTime=2019-01-08, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd3615e46273, moduleTitle=JAMA Intern Med：癌症临床试验：无进展生存期更长表明患者生活质量更佳？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd3615e46273)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378200, encodeId=121313e8200f3, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=NEJM：转移性鳞状非小细胞肺癌一线治疗免疫治疗+化疗生存期更长, objectType=article, longId=156874, objectId=8cbd1568e475, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8cbd1568e475, replyNumber=0, likeNumber=78, createdTime=2018-12-29, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8cbd1568e475, moduleTitle=NEJM：转移性鳞状非小细胞肺癌一线治疗免疫治疗+化疗生存期更长, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8cbd1568e475)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378199, encodeId=527c13e819923, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=NEJM：局限性前列腺癌接受前列腺根治术可显著延长生存期, objectType=article, longId=155732, objectId=42ac155e322f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42ac155e322f, replyNumber=0, likeNumber=113, createdTime=2018-12-15, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42ac155e322f, moduleTitle=NEJM：局限性前列腺癌接受前列腺根治术可显著延长生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42ac155e322f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378198, encodeId=4a9f13e8198e2, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=NEJM：Durvalumab可显著延长III期无法切除的非小细胞肺癌患者总生存期, objectType=article, longId=155723, objectId=f948155e2338, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f948155e2338, replyNumber=0, likeNumber=83, createdTime=2018-12-15, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f948155e2338, moduleTitle=NEJM：Durvalumab可显著延长III期无法切除的非小细胞肺癌患者总生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f948155e2338)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378197, encodeId=55cf13e8197b8, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=NEJM：双剑合璧！三阴性乳腺癌生存期大大延长！, objectType=article, longId=155592, objectId=47ca155592f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47ca155592f9, replyNumber=0, likeNumber=70, createdTime=2018-12-12, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47ca155592f9, moduleTitle=NEJM：双剑合璧！三阴性乳腺癌生存期大大延长！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47ca155592f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378196, encodeId=b62313e81964e, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=BMJ：PD-L1表达阴性患者 PD-1/PD-1抑制剂也能大幅延长生存期, objectType=article, longId=153166, objectId=251515316657, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=251515316657, replyNumber=0, likeNumber=80, createdTime=2018-11-11, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=251515316657, moduleTitle=BMJ：PD-L1表达阴性患者 PD-1/PD-1抑制剂也能大幅延长生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=251515316657)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378195, encodeId=1df013e81956a, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Radiology：能从MRI图像中发现提示胶质母细胞瘤生存期、手术效果的线索吗？, objectType=article, longId=152918, objectId=1968152918de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1968152918de, replyNumber=0, likeNumber=79, createdTime=2018-11-08, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1968152918de, moduleTitle=Radiology：能从MRI图像中发现提示胶质母细胞瘤生存期、手术效果的线索吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1968152918de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378194, encodeId=00e113e819492, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Ann Oncol：G-CSF+化疗可显著改善癌症患者的总生存期？, objectType=article, longId=152047, objectId=682715204e1c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=682715204e1c, replyNumber=0, likeNumber=91, createdTime=2018-10-29, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=682715204e1c, moduleTitle=Ann Oncol：G-CSF+化疗可显著改善癌症患者的总生存期？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=682715204e1c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378193, encodeId=2d4113e8193d5, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Lung Cancer：多学科团队会诊是否会改善肺癌生存期？, objectType=article, longId=151822, objectId=615c151822a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=615c151822a7, replyNumber=0, likeNumber=77, createdTime=2018-10-26, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=615c151822a7, moduleTitle=Lung Cancer：多学科团队会诊是否会改善肺癌生存期？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=615c151822a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378192, encodeId=c16713e819227, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=NEJM：免疫治疗在晚期三阴乳腺癌III期临床试验中成功！中位总生存期提高61.3%, objectType=article, longId=151769, objectId=5ffc151e69a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ffc151e69a2, replyNumber=0, likeNumber=97, createdTime=2018-10-25, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ffc151e69a2, moduleTitle=NEJM：免疫治疗在晚期三阴乳腺癌III期临床试验中成功！中位总生存期提高61.3%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ffc151e69a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378191, encodeId=848e13e819168, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=我国九成胃癌发现时为进展期，早诊断早治疗可延长患者生存期, objectType=article, longId=151013, objectId=8a20151013f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a20151013f2, replyNumber=0, likeNumber=59, createdTime=2018-10-16, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a20151013f2, moduleTitle=我国九成胃癌发现时为进展期，早诊断早治疗可延长患者生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a20151013f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378190, encodeId=37e213e8190d2, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Thorax：恶性中央气道阻塞治疗性支气管镜检查后的长期质量调整生存期, objectType=article, longId=149706, objectId=5eac149e06d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5eac149e06d1, replyNumber=0, likeNumber=65, createdTime=2018-09-28, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5eac149e06d1, moduleTitle=Thorax：恶性中央气道阻塞治疗性支气管镜检查后的长期质量调整生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5eac149e06d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存期

2020-05-29

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

Radiology：直肠癌晚期壁外静脉受侵MRI征象与肿瘤复发和整体生存期的关系

2019-03-27

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

Radiology：容积多参数MRI在预测型经导管动脉化学栓塞术后不可切除性肝内胆管细胞癌的生存期

2019-03-20

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

BMJ：英国心衰患者生存期变化趋势研究——2000-2017

2019-02-22

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

人工智能可以预测卵巢癌患者的生存期吗？

2019-02-20

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

Radiology：胶质母细胞瘤MRI放射组学亚型对预测生存期的价值

2019-02-15

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

Lancet Oncol：雷莫芦单抗Ⅲ期REACH-2研究获成功，AFP升高的晚期肝细胞癌患者生存期显著改善

2019-02-14

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

BLOOD：阿扎胞苷治疗可改善老年AML患者的无病生存期

2019-01-15

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

CA-Cancer J Clin：**医学期刊CA发文-生存期可超过10年！手术为转移性软组织肉瘤患者带来生存获益

2019-01-11

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

JAMA Intern Med：癌症临床试验：无进展生存期更长表明患者生活质量更佳？

2019-01-08

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

NEJM：转移性鳞状非小细胞肺癌一线治疗免疫治疗+化疗生存期更长

2018-12-29

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

NEJM：局限性前列腺癌接受前列腺根治术可显著延长生存期

2018-12-15

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

NEJM：Durvalumab可显著延长III期无法切除的非小细胞肺癌患者总生存期

2018-12-15

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

NEJM：双剑合璧！三阴性乳腺癌生存期大大延长！

2018-12-12

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

BMJ：PD-L1表达阴性患者 PD-1/PD-1抑制剂也能大幅延长生存期

2018-11-11

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Radiology：能从MRI图像中发现提示胶质母细胞瘤生存期、手术效果的线索吗？

2018-11-08

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Ann Oncol：G-CSF+化疗可显著改善癌症患者的总生存期？

2018-10-29

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Lung Cancer：多学科团队会诊是否会改善肺癌生存期？

2018-10-26

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

NEJM：免疫治疗在晚期三阴乳腺癌III期临床试验中成功！中位总生存期提高61.3%

2018-10-25

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

我国九成胃癌发现时为进展期，早诊断早治疗可延长患者生存期

2018-10-16

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Thorax：恶性中央气道阻塞治疗性支气管镜检查后的长期质量调整生存期

2018-09-28

科室
- - 订阅+
  - 更多科室
工具
服务